(123)i-meta-iodobenzylguanidine
(123)i-mibg
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
2-vessel cad
2-way anova
3-vessel cad
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
aac
abcc2
abcd classification
absorptiometry
acc
acetylcholinesterase inhibition
acetylcholinesterase inhibitor
acute rv failure
adenoviral
adjusted odds ratio
adjuvant
adrenergic
adrenomedullin
adverse events
adverse outcome
adverse outcomes
aetiologies
african americans
afterload
akt→forkhead box class o-1 signaling
aldactone
aldosterone antagonism
aldosterone blockade
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmissions
allogeneic
amino-terminal pro-b-type natriuretic peptide
amyloidotic
anabolic
anaerobic threshold
anesthetized
ang ii
ang ii infusion
angeli's salt
angii
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme inhibitors
angiotensin ii  infusion
angiotensin receptor neprilysin inhibitor
angiotensin receptors blockers
angiotensin-converting enzyme inhibitor
angiotensin-converting enzyme inhibitors
angiotensin-receptor blocker
angiotensin-receptor blockers
angiotensin-receptor neprilysin inhibitors
ann arbor veterans' affairs
annular ms
antagomir
antagonism
antagonist
anterior leaflet
anti-inflammatory
antiadrenergic
antiarrhythmic
antihypertensive medication
antiplatelet drugs
antiplatelet medication
antitumor
aortic
aortic pressure
aortic valve insufficiency
apex
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arginine vasopressin
arni inhibitors
arteries
artery
artery tonometry
arthritis
asymptomatic
at1 receptors
atherosclerosis risk in communities
atherosclerotic
atpase
atrial explants
atrioventricular
attrition
autologous
autonomic nervous system
b natriuretic peptides
b-type natriuretic peptides
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
barriers to exercise score
baseline
basic helix-loop-helix
benign tumors
beta-adrenergic responses
biomedical
bioprosthetic aortic valve replacement
biopsy
blood cell
blood flow
blood urea nitrogen
bolus
bone morphogenetic protein 4
bottleneck stenting
bpm
brain
brd4
bromodomain
bromodomain-containing protein 4
btt
bundle branch morphology
c statistic
c statistics
c termini
c'd
c-kit+ cell
c-kit+ cells
c-kit+ progenitors
c-terminally
ca(2+)
ca(2+) handling
ca(2+) sensitivity
ca2(+)
ca2+
california office of statewide health planning and development patient discharge data nonpublic file
camp signaling
candesartan
candesartan in heart failure assessment of reduction in mortality and morbidity
carcinoma
cardiac defibrillator
cardiac energy metabolism gene expression
cardiac event
cardiac functions
cardiac index
cardiac magnetic resonance imaging
cardiac magnetic resonance postcontrast t1 time
cardiac metabolic gene expression
cardiac overexpression
cardiac progenitor function
cardiac sodium
cardiac transplants
cardiac troponin t
cardiac vegf expression
cardiac volume
cardiac volume overload
cardiogenic
cardiography
cardiology-cardiovascular surgery consensus report
cardiomyiopathy
cardiopulmonary exercise test
cardiopulmonary exercise testing
cardiovascular event
cardiovascular function
cardiovascular outcomes in renal atherosclerotic lesions
cardioverter defibrillators
carotid intima-media thickness
case-fatality rate
caspase 3
catecholamines
catheter
catheterisation
cav1.2
cav1.3
cd133+ cells
cd34+vegfr2+ cells
cell adhesion genes
cells
centers for medicare and medicaid services
central glycosylated region
centrifugal flow pump
cerebral
cerebrovascular
cfi
cgmp
cgmp synthesis
chagas' disease
chamber
cha₂ds₂vasc score
chest
china
chronic acf
chronic advanced heart failure
chronic hfpef
chronic organ failure
chronic pah
chronic renal failure
chronic thromboembolic pulmonary hypertension
chronotropic response
ci
circulatory
circumflex artery
citrate cycle
ckd
clcnka
clinic
clinical practice guidelines
clinically
clinician
clinicians
clinics
cluster analysis
co-morbidities
co-morbidity
co-primary outcome
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
combined end point
comorbid
comorbidity
compensated hfpef
compensated lv hypertrophy
composite end point
composite end-point
composite primary outcome
confidence intervals
congenital
connecticut
contemporaneous control group
continuity equation
continuous flow
continuous wave doppler echocardiography
continuous-flow lvads
contractile response
contracting
cooper center longitudinal study
coprimary end points
coronary artery bypass
coronary artery bypass grafting
coronary artery bypass surgery
coronary artery calcium scores
coronary microembolization-induced hf
correlate
correlated
correlates
correlation
correlations
covariate
covariate adjustment
covariates
cox hazard models
cox modeling
cox proportional hazard analyses
cox proportional hazard models
cox proportional hazards analyses
cox proportional hazards models
cox proportional hazards regression modeling
cox regression analysis
creatine
cronbach's α
crossover study
crt
crt-d
curative
cyclase
cyclic adenosine monophosphate
cyclic guanosine monophosphate
cytochrome c
cytoskeleton
cytotoxic
cα
dapc protein
dash/srd
deaths
decompensated heart failure
decompensated hf
decompensated systolic heart failure
decompensation
defibrillation
defibrillators
deficit index
degenerative mitral regurgitation
denervation
descriptive statistics
destination therapy
dhand
diagnosed
diagnoses
diagnosis
diagnostic
diastolic filling time
diastolic mitral annulus velocity
diastolic mitral leaflet motions
differential analysis
differential effect
differentially expressed genes
dilated
dilated lv
dilation
discharges
diseased
diseases
doppler mitral inflow velocity
double-blind
downregulated
downstream signaling
downstream signalling
dpp-4
dpp-4 inhibitors
driveline
drs
dual energy x-ray absorptiometry
dual x-ray absorptiometry
dual-energy x-ray absorptiometry
duke activity status index
e/e'
early treatment of atrial fibrillation for stroke prevention trial
east
echo-derived pulmonary arterial systolic pressure
edema
edge-to-edge anastomosis
effector molecules
electrocardiographic q waves
embolectomy
embolism
embolize
emergency room
end point
end points
end stage heart failure
end-diastolic volume index
end-point
end-stage hf
end-systolic volume
endopeptidase inhibitors
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
eo-cfu
ephesus
epidemic
epigenetic
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
estimated glomerular filtration rate
etiologies
evidence based practice centres
evidence-based
exercise oscillatory ventilation
exercise tolerance
exercise-induced pulmonary artery systolic pressure
explant
exploratory factor analysis
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extra corporeal membrane oxygenation
extracellular
extracellular flux analyzer
extracorporeal support
ffm
fibrillation
fluorescence resonance energy transfer
follow up
follow-up duration
followed up
followed-up
fractional flow reserve
free wall cs
free wall rs
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
functional electrical stimulation
functional enrichment analysis
functional status
g-protein-coupled receptor
gadolinium-chelate
gdmt
gem/kir
gene expression profile
gene expressions
gene induction
general anaesthesia
genomic
genotype
genotyped
get with the guidelines-heart failure
gill index
global gene expression
global left ventricular longitudinal systolic strain
gls
glucocorticoids
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
habc battery
haematopoietic
haplotype
hazard ratios
health abc hf model
health abc hf risk model
health care
health-care
healthcare common procedure coding system codes
heart  failure
heart beat
heart failure - a controlled trial investigating outcomes in exercise training
heart failure adherence and retention trial
heart failure and reduced ejection fraction
heart failure patient severity index
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart iron
heart magnetic resonance imaging
heart muscle
heart sound
heart-specific irs1 and irs2 gene double-knockout
hek
hemodynamic phenotype
hemostasis
hf index
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
hh
hhd
hm ii
hno donor
homozygous
hospital anxiety and depression scale
hospital compare
hospitalisations
hospitalizations
hr variability
hrv
human induced pluripotent stem cell-derived cardiomyocytes
human-to-human contact
human-to-machine interface
hypertensive heart failure with preserved ejection fraction
hypertensive hfpef
hypertensive lv dysfunction
hypertrophic
hypertrophied
icd shocks
il6
implantable cardioverter defibrillator
implantable cardioverter defibrillators
implantable cardioverter-defibrillators
implantable defibrillators
in vitro
in vivo coronary perfusion
incidence
incremental shuttle walk test
infarction
infection
ingenuity pathway analysis
injected
inoperable
insignificantly
insulin receptor substrates 1
integrated discrimination improvement
intensive care
intensive care unit
intention-to-treat
interaction term analysis
interagency registry for mechanically assisted circulatory support
interatrial
international right heart foundation working group
interquartile range
interventricular
interventricular septum
intestinal
intracellular
intraclass correlation coefficient
intramuscular testosterone supplementation
intravenous
intravenous bolus
intravenously
invasive
invasive hemodynamic assessments
invasively
inverse correlation
ischaemia
ischemic mr
isoelectric focusing
isoforms
isolated coronary artery bypass grafting
italy
ivc occlusion
japan
jehovah's witness
joanna briggs institute evidence based practice
jugular
ka renal chloride channel gene
kansas city cardiomyopathy questionnaire
kaplan-meier analyses
kappa coefficients
kcl-ki
kidney disease
kinase
kinase-2
kv4.3
l-type ca2(+) current
l-type ca2+ currents
l-type currents
l-type voltage-gated ca(2+) channels
lcz696
lean mass quantification
left anterior descending artery
left anterior descending coronary artery occlusion
left atrial
left atrial area
left atrium
left bundle branch block
left bundle branch block pattern
left bundle-branch block
left heart twist
left pulmonary artery
left ventricle end-diastolic pressure
left ventricular assist devices
left ventricular assist system
left ventricular base
left ventricular dd
left ventricular diastolic end diameter
left ventricular diastolic function
left ventricular dilatation
left ventricular dysfunction
left ventricular ejection fractions
left ventricular ejection time
left ventricular end-diastolic pressure
left ventricular filling
left ventricular filling pressure
left ventricular function
left ventricular hypertrophy
left ventricular systolic dysfunction
lesion
leu3
likelihood ratio
linear mixed models
linear models
lipid
lipoprotein
liver-specific irs1 and irs2 double-knockout
log rank
log-rank testing
longitudinal
longitudinal rv fiber shortening
lv assist device
lv assist device implantation
lv assist device implantations
lv compliance
lv contractile function
lv contractility
lv diastolic dysfunction
lv diastolic stiffness
lv dilatation
lv dysfunction
lv ef
lv ejection fraction
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic volume
lv end-systolic volume
lv fibrosis
lv filling pressure
lv filling pressures
lv fractional shortening
lv function
lv hypertrophy
lv internal diameter
lv mass
lv posterior wall
lv relaxation
lv remodeling
lv reverse remodeling
lv strain
lv strain rate
lvad therapy
madit-crt
magnetic resonance angiography
mass spectrometric analysis
massive embolism
maximal ventricular power index
maximum oxygen consumption
mdc
medical outcomes study short-form
medically
medicare patient safety monitoring system
medicines
mena deletion
mesenchymal
messenger rna
meta-analyses
meta-analysis
meta-analyzed
metabolic pathways
michigan
microembolization
midregional proanp
mild heart failure
mild hf
minimal detectable change
minnesota living with heart failure questionnaire
minnesota quality of life
mitochondrial complex v activity
mitochondrial oxidative phosphorylation capacity
mitochondrial proteome
mitogen-activated protein kinase
mitral annular velocity
mitral annulus velocities
mitral annulus velocity
mitral leaflet motions
mitral valve area
mitral valve plasty
mixed linear models
mixed models
mixed-methods study
mlhf questionnaire
morbidities
morbidity
morpholino-based
mpsms
mri scanner
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multivariable analysis
multivariable models
multivariable-adjusted hazard ratios
multivariate analyses
multivariate analysis
multivariate cox model
multivariate cox proportional hazards regression modeling
multivariate cox regression analyses
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
muscular
myocardial oxygen consumption
myocardial t1
myocyte differentiation
myocyte-specific mena overexpression
myofiber shortening
myosin
myxoma
n-terminal pro-b-type natriuretic peptides
n-terminal pro-b-type np
n-terminal pro-brain-type natriuretic peptide
n-terminal probnp
n2bus
na+ channel
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
narrow qrs complex
national cardiovascular disease registry practice innovation and clinical excellence registry
natriuretic
ncdr pinnacle
neprilysin inhibitors
net reclassification improvement
neuro-hormonal
neurohormonal
neurohormonally
neurohumoral
new york heart association class
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association classes
new york heart association classification
new york heart association functional class
no
non-biological disease modifying antirheumatic drug
non-dilated left ventricle
non-invasively
non-ischemic heart failure
noncardiovascular
noninvasive
nonischemic
nonischemic cardiomyopathies
nonmitochondrial
nonmitochondrial protein
nonselective β-blocker
nonsignificant
nonterminal epitopes
nontrastuzumab users
north america
nosignificant
nris
nt-pro bnp
nuclear factor of activated t cells
nuclear factor-κb
nurse practitioner
nyha class
nyha class iii
nyha class iiib
nyha classification
nyha functional class
nyha functional class ii
nyha functional class iii
nyha functional class iv
observational cohort studies
observational cohort study
odds ratio
odds ratios
oedema
ontario
operation
operations
operative
or
oral
orally
organ
organic
outcome
outcomes
p value
p values
p-value
p.arg83gly
p3 prolapse
p38
p38alpha
p38α
p70s6k
p70s6k-ser(411)
paf-cpt
palliation
palliative care
parasympathetic
partial pressure of end-tidal co2
pathogenesis
pathological
pathology
pathophysiological
pathophysiologically
paucity
pde2 inhibition
pdrelated
peak early diastolic mitral annular velocity
peak early diastolic mitral flow velocity
peak o2
peak oxygen uptake
peak quadriceps force
peak respiratory quotient
peak work rate
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
perfusion
periodic breathing
perioperative
peripheral muscle
petco2
pharmacological
phenotype
phenotypes
physical
physical examination
physio ring 30
physiologic
physiological
physiology
pkc-βii-ser(660)
placebo
plasma b-type natriuretic peptide
plasma membrane translocation
plasma n-terminal pro-b-type natriuretic peptide
plasma nps
pluripotency markers
point of care
polymerase ii
post hoc analysis
post-lvad ai
postcontrast t1
postexercise phosphocreatine resynthesis
postoperatively
postsystolic function
power spectral analysis
ppr
precapillary ph
prescribed
preserved ef
preserved left ventricular ejection fraction
preserved left ventricular ejection fractions
preserved lv ejection fraction
preserved lvef
pressure ulcers
pressure volume relation
prevalence
primary composite endpoint
primary end point
primary endpoint
primary outcome
primary outcomes
pro bnp
pro2
pro6
pro75
proangiogenic
probnp
prodrug
progenitor
progenitor cells
progenitors
prognosis
prognostic
prognostically
proof-of-principle cohort study
prospective studies
prospective study
prospectively
protein expression
protein kinase a
protein kinase r-like er kinase
proteolysis
proteomic
psychosocial
pulmonary arterial systolic pressure
pulmonary artery systolic pressure
pulsatile afterload
qrs complex
qrs duration
qrs morphology
qrs prolongation
qt interval
qt intervals
qt variability
r
r-r interval
rad variant
raf-mek1/2-erk1/2 scaffold proteins
raf-mek1/2-erk1/2 signalling pathway
raft
random-effects models
randomised
randomised-controlled trials
randomization
randomize
randomized
rankin score
ras blockers
rate ratio
receptor
receptors
red blood cell
red blood cell transfusion
redo sternotomy
reduced ef
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression analysis
regression line
regression modeling
regression models
relative risk
relative wall thickness
renal optimization strategies evaluation
renin
renin inhibitors
renin- angiotensin-aldosterone pathway
renin-angiotensin-aldosteron
renin-angiotensin-aldosterone system inhibitors
reoperation
reperfusion
repolarization
respiratory gas analysis
resting hemodynamics
resting tension
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
resynchronization-defibrillation for ambulatory heart failure trial
retrospective cohort
retrospective cohort study
retrospective matched cohort study
reverse
rgk protein
rgk proteins
rheumatoid
rhythm control
right atrial
right heart circulatory failure
right heart filling pressures
right pulmonary artery
right ventricle
right ventricular assist device
right ventricular assist devices
right ventricular contractile function
right ventricular contractile reserve
right ventricular dysfunction
right ventricular ejection fraction
right ventricular end-diastolic area index
right ventricular fractional area
right ventricular function
right ventricular pacing
right ventricular pressure overload
right ventricular support
right ventricular-pulmonary arterial coupling
riiα
rmsea
rotterdam study
rs10927887
rtq-pcr
rv decompensation
rv function
rv support
rvad
rvads
rwt
s'
s12884
s1pr1 agonist
s3991
sa
sarcopenic range muscle wasting
schfi v.6.2
sd of all qt intervals
sd of rr intervals
sdrr
seattle heart failure model
secondary end point
secondary end points
secondary endpoints
secondary outcome
secondary outcomes
selective beta-blockers
selective β-blocker
self-care maintenance
self-care of heart failure index version 6.2
ser96
serum albumin
serum creatinine
serum cystatin c
severe heart failure
severe hf
severe systolic heart failure
severe systolic hf
short-term fractal scaling exponent
shotgun lc-ms/ms
shunt
shunting
shuttle walk test
signal transduction
signaling pathway
signaling pathways
signalling pathway
signalling pathways
signalling proteins
signalosome complex
significance
significant
significantly
smad 2/3
spearman correlations
specificity
speckle tracking echocardiography
sphingosine-1-phosphate receptor 1
spontaneous ventricular tachycardia
spontaneous vt
sr ca(2+)-pump
st-segment-elevation mis
stable
stable heart failure
stable hf
standard error of measurement
sternal
stress doppler echocardiography
stress echocardiography
stroke volume
stroke volume index
strokes
structured telephone support
student t test
subclinical
subproteome
subproteomes
surgeons
surgically
sweden
sympathetic control of heart rate
symptom
symptomatic
symptomatic adult fontan
symptomatic chronic advanced heart failure
symptomatic systolic heart failure
symptoms
syndrome
syndromes
systemic
systolic  heart failure
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic left ventricular dysfunction
systolic mitral annulus velocity
systolic volume index
t1
t1 time
t1 times
t1-mapping
t2*
tachyarrhythmias
tachycardic
tachypacing-induced hf
taub
telemonitoring
terminal
terminal heart failure
testosterone supplementation
texas
texas cancer registry–medicare
tgf-β
tgf-β receptor type i
tgf-β signaling
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
therapeutics
third heart sound
thr197
thromboembolic
thromboembolism
thrombotic
timed up & go test
tissue doppler
tissuefaxs
titrated
tm24/7
tnf antagonist
tnf antagonists
tonometric
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
total arterial compliance
transcatheter aortic valve procedure
transduction pathways
transforming growth factor-β
transient receptor potential cation channel m7
transmitral
transmitral blood flow velocity
transoesophageal echocardiographic
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin i
troponin t
trpm7
tta/tgtetmena
tug
tug test
tumor
tumors
tunel-positive cells
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
undiagnosed
unilateral renal denervation
unilateral renal dnx
univariable analysis
univariate analysis
university of connecticut heart failure center
uptitration
uptitrations
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
vascular
vascular disease
vascular endothelial growth factor blockade
vascular stiffness
vasodilators
vasopeptidase inhibitors
vasopressin type 2 receptor antagonist
vegf inhibition
vegf signaling pathway
ven/vco2 slope
vena cava
venous
venous thromboembolism
ventilatory efficiency slope
ventricular action potential
ventricular action potentials
ventricular fibrillation
ventricular function
ventricular systolic hf
ventricularly
video edge detection
vo2 max
vo2max
volume overload
von willebrand factor
western australia
wide qrs complex
wilcoxon matched-pairs signed-rank tests
wild-type rad
women's health initiative
x-ray
xanthine oxidase inhibition
yorkshire
z-score
zung self-rated depression scores
β coefficient
β-adrenergic receptor blockade
β-adrenergic receptor blocker therapy
β-ar responsiveness
β1ar
